Phase 2 Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with squamous cell carcinoma (a type of cancer) of the anal canal or anal margin, confirmed by a tissue test. This includes certain related cancer cell types (such as basaloid or cloacogenic).
- People whose cancer is at a stage that has not spread to distant parts of the body, based on standard cancer staging guidelines (confirm with trial site).
- People whose treating doctor considers them suitable for radiation therapy, either alone or combined with chemotherapy, as their main treatment.
- People who are 18 years of age or older.
- People who are reasonably active and able to care for themselves, as measured by a standard medical scoring tool called the ECOG performance scale (scores 0–2, meaning fully active to capable of self-care but unable to do heavy physical work).
Who may not be able to join:
- People who have previously received chemotherapy, radiation therapy, or major surgery intended to cure their anal cancer.
- People who have previously had radiation therapy to the abdomen or pelvis in a way that would overlap with the radiation treatment area used in this trial.
- People who have a history of another type of cancer, unless they have been free of that cancer for at least 2 years and their doctor considers the risk of it returning to be low. An exception applies for people diagnosed and treated within the past 5 years for cervical cancer in situ, or basal cell or squamous cell carcinoma of the skin — those people may still be considered eligible.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 416-946-2360
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Change in locoregional failure (LRF) at Year 2
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.